COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01905137
Recruitment Status : Active, not recruiting
First Posted : July 23, 2013
Last Update Posted : April 12, 2019
Information provided by (Responsible Party):
Sybil Dessie, MD, Boston Urogynecology Associates

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 9, 2018
Estimated Study Completion Date : June 2019